drugset / Trial / NCT05638282
A Study to Evaluate the Safety and Tolerability of Cendakimab in Chinese Healthy Participants
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the drug levels, safety, and tolerability of cendakimab in healthy male and female Chinese participants.
Timeline
- Start
- 2023-02-15
- Primary completion
- 2023-06-27
- Completion
- 2023-06-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cendakimab | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.